Form 4: Stryker Corp Executive Becker Acquires Shares Following Performance Goal Achievement

Yin C. Becker, VP and Chief Corporate Affairs Officer of Stryker Corp, acquired 1,746 shares of common stock on March 10, 2025, following the achievement of pre-established performance goals.

Summary

• On March 10, 2025, Yin C. Becker, VP and Chief Corporate Affairs Officer of Stryker Corp, acquired 1,746 shares of common stock.
• The acquisition was based on the achievement of pre-established three-year adjusted diluted net earnings per share and sales performance goals.
• These shares vest on March 21, 2025.
• Following the transaction, Becker directly owns 34,544 shares of common stock and indirectly owns 2,382 shares through a 401K.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The acquisition of shares by an executive based on achieving performance goals suggests confidence in the company's past performance and future prospects. However, it's a routine filing and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• The acquisition of shares by a company executive signals confidence in Stryker's performance and future prospects.
• Achievement of performance goals indicates successful execution of the company's strategy.

Future Outlook

The document does not contain specific forward-looking statements, but the share acquisition based on performance goals suggests a positive outlook based on past achievements.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's performance and future prospects. This acquisition, tied to performance goals, suggests alignment between executive compensation and company success.

Comparison to Industry Standards

• Comparing Stryker's executive compensation structure to industry peers like Medtronic (MDT), Johnson & Johnson (JNJ), and Boston Scientific (BSX) would provide context on whether the performance goals and share-based compensation are competitive.
• Benchmarking Stryker's adjusted diluted net earnings per share and sales performance against these competitors would further illuminate the company's relative success.
• Analyzing similar Form 4 filings from executives at these companies can reveal trends in insider trading activity and compensation practices within the medical device industry.

Stakeholder Impact

• Shareholders may view the share acquisition positively, as it aligns executive interests with company performance.
• Employees may be motivated by the achievement of performance goals, which led to the share acquisition.

Key Dates